GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MediciNova Inc (TSE:4875) » Definitions » Shiller PE Ratio

MediciNova (TSE:4875) Shiller PE Ratio : (As of Dec. 14, 2024)


View and export this data going back to 2005. Start your Free Trial

What is MediciNova Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MediciNova Shiller PE Ratio Historical Data

The historical data trend for MediciNova's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediciNova Shiller PE Ratio Chart

MediciNova Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MediciNova Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MediciNova's Shiller PE Ratio

For the Biotechnology subindustry, MediciNova's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediciNova's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MediciNova's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where MediciNova's Shiller PE Ratio falls into.



MediciNova Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

MediciNova's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, MediciNova's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-8.577/133.0289*133.0289
=-8.577

Current CPI (Sep. 2024) = 133.0289.

MediciNova Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 -11.932 99.070 -16.022
201503 -10.836 99.621 -14.470
201506 -11.395 100.684 -15.056
201509 -7.209 100.392 -9.553
201512 -10.947 99.792 -14.593
201603 -12.422 100.470 -16.447
201606 -10.535 101.688 -13.782
201609 -8.143 101.861 -10.635
201612 -4.640 101.863 -6.060
201703 -10.162 102.862 -13.142
201706 -8.873 103.349 -11.421
201709 -12.185 104.136 -15.566
201712 -5.647 104.011 -7.222
201803 -12.726 105.290 -16.079
201806 -8.805 106.317 -11.017
201809 -17.936 106.507 -22.402
201812 -1.122 105.998 -1.408
201903 -12.226 107.251 -15.165
201906 -9.726 108.070 -11.972
201909 -5.377 108.329 -6.603
201912 -4.364 108.420 -5.355
202003 -6.460 108.902 -7.891
202006 -10.758 108.767 -13.158
202009 -8.447 109.815 -10.233
202012 -6.228 109.897 -7.539
202103 -0.429 111.754 -0.511
202106 -9.910 114.631 -11.500
202109 -7.711 115.734 -8.863
202112 -4.553 117.630 -5.149
202203 -8.300 121.301 -9.102
202206 -10.717 125.017 -11.404
202209 -10.030 125.227 -10.655
202212 -8.095 125.222 -8.600
202303 -8.020 127.348 -8.378
202306 -8.481 128.729 -8.764
202309 -1.478 129.860 -1.514
202312 -5.759 129.419 -5.920
202403 -8.989 131.776 -9.074
202406 -7.893 132.554 -7.921
202409 -8.577 133.029 -8.577

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


MediciNova  (TSE:4875) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


MediciNova Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of MediciNova's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MediciNova Business Description

Traded in Other Exchanges
Address
4275 Executive Square, Suite 300, La Jolla, CA, USA, 92037
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

MediciNova Headlines

No Headlines